Translating genomics from bench to bedside is the foundation of Dr. Craig's research. He co-founded the CAP/CLIA-accredited Ashion Labs. Also, he helped start TGen's Center for Rare Childhood Disorders (C4RCD.org) and got over a thousand families to join the study of diseases with unknown genetic causes. His group has worked to develop shared standards and datasets, serving as a co-PI on 1000 Genomes. (i) Neurological disorders. He has had collaborative publications in bipolar disorder (>45 pubs), Alzheimer's disease (>15 pubs), and pediatric neurology (>30 pubs). As part of the Accelerated Medicine Partnership in Parkinson's Disorder (AMP-PD), his group recently led the longitudinal analysis of over 8,500 transcriptomes from 1600 people. (ii) Oncology. His research in somatic heterogeneity and disease progression has led to collaborations developing genomic methods in oncology. His group was one of the first to study whole-genome and transcriptome profiling to treat metastatic triple-negative breast cancer.